輔助生殖技術（ART）市場：依產品類型、技術、流程、最終用戶和地區分類

Assistive Reproductive Technology Market, By Product Type, By Technology, By Procedures, By End User, By Geography

出版日期: 2026年02月04日 | 出版商:

Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

輔助生殖技術（ART）市場預計在2026年達到357億美元，預計2033年將達到512億美元。預計從2026年到2033年，其複合年成長率將達到7.8%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	357億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	7.80%	2033年市場規模預測：	512億美元

輔助生殖技術（ART）是不孕症治療方法之一。此方法將精子和卵子從體內取出，在實驗室環境中進行體外受精。這種體外受精過程稱為體外受精（IVF）。體外受精主要分為兩種：「卵胞漿內單一精子注射（ICSI）輔助體外受精」和「非卵胞漿內單一精子注射（ICSI）輔助體外受精」。

市場動態

近年來不孕症率的上升推動了全球輔助生殖技術（ART）市場的成長。例如，根據歐洲人類生殖與胚胎學會（ESHRE）2018年的數據，超過800萬名嬰兒透過體外受精（IVF）出生。 IVF手術數量的增加預計將進一步促進全球ART市場的成長。

不孕症的日益普遍推動了輔助生殖技術（ART）的需求。此外，使用新鮮卵子和非捐贈卵子的ART週期妊娠和分娩成功率的不斷提高，預計將進一步促進市場成長。例如，根據2016年體外受精（IVF）出生率統計數據，約有650萬個嬰兒經由IVF出生。此外，根據美國疾病管制與預防中心（CDC）的數據，美國每年約有1.6%的新生兒是透過ART受孕的。

輔助生殖技術（ART）週期採用多種方法進行，包括新鮮供卵、冷凍供卵、新鮮非供卵、冷凍非供卵以及胚胎/卵子庫。方法的選擇會影響ART市場的成長，而所採用的技術類型也會影響方法的選擇。根據美國疾病管制與預防中心（CDC）的數據，2015年，美國新鮮非供卵方法佔26%，冷凍非供卵方法佔42%。預計這些因素將推動全球ART市場的成長。

影響全球輔助生殖技術（ART）市場的因素。

這個市場的主要限制因素之一是法律監護權問題，包括人們對出生證明上會顯示誰的名字以及誰將承擔父母責任的擔憂。這些因素可能會阻礙父母使用輔助生殖技術（ART）。

本次調查的主要特點。

本報告指出了各個細分市場的潛在商機，並說明了該市場中具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、區域前景以及主要企業採取的競爭策略的重要見解。
本報告根據以下參數對全球輔助生殖技術 (ART) 市場的主要企業進行了分析：公司概況、財務績效、產品系列、企業發展區域、分銷策略、主要發展、策略和未來計劃。
透過利用本報告中提出的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
本報告面向該產業的各類相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用分析輔助生殖技術 (ART) 市場中使用的各種策略矩陣來簡化決策過程。

Report Coverage	Report Details
Base Year:	2025	Market Size in 2026:	USD 35,700 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	7.80%	2033 Value Projection:	USD 51,200 Mn

Assistive reproductive technology (ART) is an infertility treatment procedure. In this procedure, the sperm and eggs are taken out of the body and oocyte fertilization is done under laboratory environment. The fertilization process carried outside the body is known as In vitro fertilization (IVF). There are mainly two type of IVF procedures such IVF with Intracytoplasmic Sperm Injection (ICSI) and IVF without Intracytoplasmic Sperm Injection (ICSI).

Market Dynamics

Increase in infertility rates over the past years has supported growth of global assistive reproductive technologies market growth. For instance, according to the European society of Human Reproduction and Embryology (ESHRE) in 2018, more than 8 million babies, were born from IVF procedure. This rising number of IVF procedures is expected to boost the global assistive reproductive technology market growth.

Rising prevalence of infertility cases has led to an increase in demand for ART treatment techniques. Furthermore, higher rate of successful pregnancies and births resulting from ART cycles using fresh nondonor eggs or embryos is expected to facilitate the market growth. For instance, in 2016, as per IVF birth rate statistics, around 6.5 million babies were born using in-vitro fertilization (IVF). Moreover, according to the Centers for Disease Control and Prevention (CDC), around 1.6 percent of babies born in the United States each year are conceived through assisted reproductive technology (ART).

ART cycles, are carried out using various procedures such as fresh donor, frozen donor, fresh nondonor, frozen nondonor and embryo/egg banking. The choice of procedures also affects growth of the assistive reproductive technology market, depending upon the type of technology procedures are also chosen. In 2015, according to Centers for Disease Control and Prevention (CDC) 26% fresh nondonor and 42% frozen nondonor procedures were performed in the U.S. These factors are expected to propel the global assistive reproductive technology market growth.

Restraints of the Global Assistive Reproductive Technology Market

One of the major restraints of this market is the issue of legal parental rights, and few concern of people such as, whose names will be there on birth certificate and who will have parental responsibility. Such factors may refrain parents to make use of assistive reproductive technologies.

Key features of the study

This report provides in-depth analysis of the global assistive reproductive technology market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019-2027), considering 2018, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global assistive reproductive technology market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
Key companies covered as a part of this study include Cooper Surgical Inc., Hamilton Thorne, Inc., FUJIFILM Irvine Scientific, Inc., Merck KGaA, Nidacon International AB, Vitrolife AB, EMD Serono, Inc., INVO Bioscience, IVFtech ApS, Gonagen Medikal, Cook Medical Llc., and CellCura ASA
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global assistive reproductive technology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the assistive reproductive technology market.

Market Segmentation

By Product Type
- Consumables
- Instruments
By Technology
- In-vitro fertilization (IVF)
- IVF with Intracytoplasmic Sperm Injection (ICSI)
- IVF without Intracytoplasmic Sperm Injection (ICSI)
- Artificial Insemination-Intrauterine Insemination (AI-IUI)
- Frozen Embryo Replacement (FER)
- Others
By Procedures
- Fresh Donor
- Frozen Donor
- Fresh Nondonor
- Embryo/Egg Banking
- Others
By End User
- Fertility Clinics
- IVF Center
- Hospital
By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
Assistive Reproductive Technology Market Key Players
- Cooper Surgical Inc.
- Hamilton Thorne, Inc.
- FUJIFILM Irvine Scientific, Inc.
- Merck KGaA
- Nidacon International AB
- Vitrolife AB
- EMD Serono, Inc.
- INVO Bioscience
- IVFtech ApS
- Gonagen Medikal
- Cook Medical LLC.
- CellCura ASA.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Technology
- Market Snippet, By Procedure
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Novel Product Launch/Approval
Acquisitions and Partnerships
Technological Advancement
Regulatory Scenario
Reimbursement Scenario
Product Recalls
PEST Analysis
PORTER's Analysis
Epidemiology

4. Global Assistive Reproductive Technology Market, By Product Type, 2026 - 2033 (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026-2033
- Segment Trends
Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Segment Trends
Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Segment Trends

5. Global Assistive Reproductive Technology Market, By Technology, 2026 - 2033 (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026-2033
- Segment Trends
In-vitro fertilization (IVF)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  - IVF with Intracytoplasmic Sperm Injection (ICSI)
  - IVF without Intracytoplasmic Sperm Injection (ICSI)
Artificial Insemination-Intrauterine Insemination (AI-IUI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Frozen Embryo Replacement (FER)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

6. Global Assistive Reproductive Technology Market, By Procedures, 2026 - 2033 (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026-2033
- Segment Trends
Fresh Donor
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Frozen Donor
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Fresh Nondonor
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Embryo/Egg Banking
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

7. Global Assistive Reproductive Technology Market, By End User, 2026 - 2033 (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026-2033
- Segment Trends
Fertility Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
IVF Center
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Hospital
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

8. Global Assistive Reproductive Technology Market, By Region, 2026 - 2033 (USD Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2026-2033
North America
- Market Size and Forecast, By Product Type, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Technology, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Procedure, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Region, 2026 - 2033 (USD Mn)
U.S.
Canada
Europe
- Market Size and Forecast, By Product Type, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Technology, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Procedure, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Region, 2026 - 2033 (USD Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Market Size and Forecast, By Product Type, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Technology, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Procedure, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Region, 2026 - 2033 (USD Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Market Size and Forecast, By Product Type, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Technology, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Procedure, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Region, 2026 - 2033 (USD Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Africa
- Market Size and Forecast, By Product Type, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Technology, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Procedure, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Region, 2026 - 2033 (USD Mn)
Central Africa
South Africa
North Africa
Middle East
- Market Size and Forecast, By Product Type, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Technology, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Procedure, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Region, 2026 - 2033 (USD Mn)
GCC
Israel
Rest of Middle East

9. Competitive Landscape

Heat Map Analysis
Company Profiles
- Cooper Surgical Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Hamilton Thorne, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- FUJIFILM Irvine Scientific, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Nidacon International AB
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Vitrolife AB
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- EMD Serono, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- INVO Bioscience
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- IVFtech ApS
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Gonagen Medikal
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Cook Medical LLC.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- CellCura ASA
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Merck KGaA
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies